MojoSort™ Human CD45 Nanobeads from BioLegend

Product Specs
ItemMojoSort™ Human CD45 Nanobeads
CompanyBioLegend
Price $740.00Supplier Page View Company Product Page
Catalog Number480030
Quantity200 tests
ApplicationsCell Separation (MojoSort™, ) - Quality tested
FormatAqueous solution containing BSA and 0.05% sodium azide
SpeciesHuman
TargetCD45

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) ImmunoPheno: A Computational Framework for Data-Driven Design and Analysis of Immunophenotyping ExperimentsbioRxivFebruary 3, 2026Lincoln Wu, Minh A. Nguyen, Zhangliang Yang, Sriya Potluri, Shamilene Sivagnanam, Nell Kirchberger, Apoorva Joshi, Kyung J. Ahn, Joseph S. Tumulty, Emylette Cruz Cruz Cabrera, et al.three fractions. One fraction of 300 million cells was depleted of CD45+ cells using magnetic beads (MojoSort Human CD45 Nanobeads; Biolegend) to enrich for non-hematopoietic cells. A second fraction of 50 million cells was similarly

(2) Chromatin Accessibility Profiling of Keratinocytes from Clinically Healed Psoriatic Skin Reveals Epigenetic AlterationsJID InnovationsJanuary 1, 2026Sayaka Shibata, Kentaro Awaji, Asumi Koyama, Haruka Taira, Toyoki Yamamoto, Lixin Li, Yukiko Ito, Shunsuke Miura, Takashi Yamashita, Takuya Miyagawa, et al.suspension. CD45-positive immune cells in the epidermis were depleted using a negative selection process by Mojosort Human CD45 Nanobeads (BioLegend, San Diego, CA) for further ATAC-seq analysis (Figure 1b). ATAC-seq and data analysis The

(3) Enhanced MHC Class‐II Expression in Fibroblastic Reticular Cells Associates with MaturationEuropean Journal of ImmunologyNovember 10, 2025Janna E. G. Roet, Catarina Gago da Graça, Michael de Kok, Daphne Panocha, Tanja Konijn, Henk P. Roest, Luc J. W. van der Laan, Lisa G. M. van Baarsen, Charlotte M. de Winde, Reina E. Mebiusobtained human LN cell suspensions were enriched for CD45neg (stromal) cells by negative selection using MojoSort Human CD45 Nanobeads (BioLegend). The manufacturer's protocol was followed, with the addition of a fluorescently labelled

(4) Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testingMolecular OncologySeptember 1, 2025Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, et al.EDTA). Depletion of CD45‐positive cells was performed using MojoSort™ Human CD45 Nanobeads (BioLegend, 480029) and MojoSort™ Magnet 5 mL (BioLegend, 480019) according to the manufacturers' instructions. Briefly,

(5) Immune responses in checkpoint myocarditis across heart, blood and tumourNatureDecember 5, 2024Steven M. Blum, Daniel A. Zlotoff, Neal P. Smith, Isabela J. Kernin, Swetha Ramesh, Leyre Zubiri, Joshua Caplin, Nandini Samanta, Sidney Martin, Mike Wang, et al.CITE-Seq buffer containing TruStain FcX blocker (Biolegend 422302) and MojoSort CD45 Nanobeads (Biolegend 480030). In batches where hashtags were used for demultiplexing, hashtag antibodies (Biolegend) were added

(6) SARS-CoV-2 infection elucidates features of pregnancy-specific immunityCell ReportsNovember 26, 2024Dong Sun Oh, Eunha Kim, Rachelly Normand, Guangqing Lu, Lydia L. Shook, Amanda Lyall, Olyvia Jasset, Stepan Demidkin, Emily Gilbert, Joon Kim, et al.buffer containing TruStain FcX blocker (BioLegend, 422302) and MojoSort CD45 Nanobeads (BioLegend, 480030). Hashtag antibodies (BioLegend) were added to samples (Table S11) followed by a 30 min incubation on

(7) Human lymph node fibroblastic reticular cells maintain heterogeneous characteristics in cultureiScienceJuly 19, 2024Roet JEG, Morrison AI, Mikula AM, de Kok M, Panocha D, Roest HP, van der Laan LJW, de Winde CM, Mebius RE.Cell Stain Kit,Thermo Fisher Scientific,Cat# L34961 MojoSortTM Human CD45 Nanobeads,BioLegend,Cat# 480029 ,, Software and algorithms,Software and algorithms,Software and algorithms ,, Multibatch Cytometry

(8) Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisNature MedicineMay 9, 2024Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P. Smith, Alice Tirard, et al.FACS buffer containing TruStain FcX blocker (Biolegend 422302) and MojoSort CD45 Nanobeads (Biolegend 480030). Individually titrated working solutions containing one of eight hashtag antibodies were added to each

(9) Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and TumorbioRxivNovember 30, 2023Steven M. Blum, Daniel A. Zlotoff, Neal P. Smith, Isabela J. Kernin, Swetha Ramesh, Leyre Zubiri, Joshua Caplin, Nandini Samanta, Sidney C. Martin, Alice Tirard, et al.CITE-seq buffer containing TruStain FcX blocker (Biolegend 422302) and MojoSort CD45 Nanobeads (Biolegend 480030). Hashtag antibodies (Biolegend) were added to samples (Supplementary Table 11) followed by a 30 minute

(10) TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against TumorsBiomedicinesOctober 16, 2023Alaa Alsalloum, Saleh Alrhmoun, Julia Shevchenko, Marina Fisher, Julia Philippova, Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Julia Lopatnikova, Vasily Kurilin, Marina Volynets, et al.we conducted positive magnetic sorting for the MojoSort™ Human CD45 Nanobeads (Biolegend, USA, cat #480029) marker. The viability of the magnetically sorted cells was then assessed using a Countess 3 Automated Cell Counter

(11) Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4International Journal of Molecular SciencesOctober 13, 2023Alaa Alsalloum, Julia Shevchenko, Marina Fisher, Julia Philippova, Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Saleh Alrhmoun, Julia Lopatnikova, Kurilin Vasily, Marina Volynets, et al.we conducted positive magnetic sorting for the MojoSort™ Human CD45 Nanobeads (Biolegend, USA, cat #480029) marker. The viability of the magnetically sorted cells was then assessed using a Countess 3 Automated Cell Counter

(12) Menin and Menin-Associated Proteins Coregulate Cancer Energy MetabolismCancersSeptember 22, 2020Chou CW, Tan X, Hung CN, Lieberman B, Chen M, Kusi M, Mitsuya K, Lin CL, Morita M, Liu Z, et al.washed by the MojoSort buffer and contaminated blood cell depletion was carried out using 10 μL of Human CD45-nanobeads (Biolegend, San Diego, CA, USA). CD45− CTCs were harvested in the supernatant by a magnetic stand after

(13) A Novel Combined Methodology for Isolation and Detection of Circulating Tumor Cells based on Flow Cytometry and Cellular Filtration TechnologiesInternational Journal of Cancer and Clinical ResearchFebruary 8, 2020Grigoriadis Nikolaos G, Kyritsis Konstantinos A, Akrivou Melpomeni G, Giassafaki Lefki-Pavlina N, Vizirianakis Ioannis S10.6) of previous Red Blood Cells (RBCs)-depleted TNCs processed with anti-CD45 immumomagnetic beads (Mojosort® Human CD45 Nanobeads, Biolegend®) according to manual guidelines for the selection of (CD45-) negative fraction, prepared accordingly

(14) Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signalingCommunications biologyJanuary 1, 2020Thapa D, Huang SB, Muñoz AR, Yang X, Bedolla RG, Hung CN, Chen CL, Huang TH, Liss MA, Reddick RL, et al.was collected following Ficoll cushion centrifugation. MojoSort™ Human CD45 Nanobeads (BioLegend, #480030) was used to deplete CD45+ cells. To enrich CTCs, we cultured cells in PRIME-XV tumorsphere medium (Irvine

Be the First to Write a Review!

MojoSort™ Human CD45 Nanobeads from BioLegend

Description

BioLegend

Citations (14)

Reviews

MojoSort™ Human CD45 Nanobeads from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map